New tests for advanced and aggressive forms of prostate cancer

Recent media releases have provided initial information about new tests for “advanced”, BRCA mutation-associated and for “aggressive” forms of prostate cancer that need immediate intervention. … READ MORE …

Of genes and patents and Myriad Genetics

In March 2010, as previously reported on this web site, a federal court judge initially ruled that the patents on the BRCA1 and BRCA2 genes held by Myriad Genetics and the University of Utah “are directed to a law of nature and were therefore improperly granted.” … READ MORE …